We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Faces More Antitrust Suits For Blocking Generic on Effexor XR
Pfizer Faces More Antitrust Suits For Blocking Generic on Effexor XR
June 19, 2012
Pfizer is again facing antitrust lawsuits from pharmacies claiming it used fraudulent tactics to block and delay generic forms of its blockbuster antidepressant Effexor XR.